Literature DB >> 24599641

Clinical, cognitive, and behavioural correlates of white matter damage in progressive supranuclear palsy.

Federica Agosta1, Sebastiano Galantucci, Marina Svetel, Milica Ječmenica Lukić, Massimiliano Copetti, Kristina Davidovic, Aleksandra Tomić, Edoardo G Spinelli, Vladimir S Kostić, Massimo Filippi.   

Abstract

White matter (WM) tract alterations were assessed in patients with progressive supranuclear palsy (PSP) relative to healthy controls and patients with idiopathic Parkinson's disease (PD) to explore the relationship of WM tract damage with clinical disease severity, performance on cognitive tests, and apathy. 37 PSP patients, 41 PD patients, and 34 healthy controls underwent an MRI scan and clinical testing to evaluate physical disability, cognitive impairment, and apathy. In PSP, the contribution of WM tract damage to global disease severity and cognitive and behavioural disturbances was assessed using Random Forest analysis. Relative to controls, PSP patients showed diffusion tensor (DT) MRI abnormalities of the corpus callosum, superior cerebellar peduncle (SCP), cingulum and uncinate fasciculus bilaterally, and right inferior longitudinal fasciculus. Corpus callosum and SCP DT MRI measures distinguished PSP from PD patients with high accuracy (area under the curve ranging from 0.89 to 0.72). In PSP, DT MRI metrics of the corpus callosum and superior cerebellar peduncles were the best predictors of global disease severity scale scores. DT MRI metrics of the corpus callosum, right superior longitudinal and inferior longitudinal fasciculus, and left uncinate were the best predictors of executive dysfunction. In PSP, apathy severity was related to the damage to the corpus callosum, right superior longitudinal, and uncinate fasciculi. In conclusion, WM tract damage contributes to the motor, cognitive, and behavioural deficits in PSP. DT MRI offers markers for PSP diagnosis, assessment, and monitoring.

Entities:  

Mesh:

Year:  2014        PMID: 24599641     DOI: 10.1007/s00415-014-7301-3

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  44 in total

1.  PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA.

Authors:  J C STEELE; J C RICHARDSON; J OLSZEWSKI
Journal:  Arch Neurol       Date:  1964-04

2.  Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy.

Authors:  N J Cordato; A J Duggins; G M Halliday; J G L Morris; C Pantelis
Journal:  Brain       Date:  2005-04-20       Impact factor: 13.501

3.  Diffusion tensor imaging and voxel based morphometry study in early progressive supranuclear palsy.

Authors:  A Padovani; B Borroni; S M Brambati; C Agosti; M Broli; R Alonso; P Scifo; G Bellelli; A Alberici; R Gasparotti; D Perani
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-11-23       Impact factor: 10.154

4.  Clinical correlates of white matter tract degeneration in progressive supranuclear palsy.

Authors:  Jennifer L Whitwell; Ankit V Master; Ramesh Avula; Kejal Kantarci; Scott D Eggers; Heidi A Edmonson; Clifford R Jack; Keith A Josephs
Journal:  Arch Neurol       Date:  2011-06

5.  Frontal atrophy correlates with behavioural changes in progressive supranuclear palsy.

Authors:  N J Cordato; C Pantelis; G M Halliday; D Velakoulis; S J Wood; G W Stuart; J Currie; M Soo; G Olivieri; G A Broe; J G L Morris
Journal:  Brain       Date:  2002-04       Impact factor: 13.501

6.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

7.  An fMRI study of the Trail Making Test.

Authors:  Konstantine K Zakzanis; Richard Mraz; Simon J Graham
Journal:  Neuropsychologia       Date:  2005-04-22       Impact factor: 3.139

8.  Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease.

Authors:  Giovanni Rizzo; Paolo Martinelli; David Manners; Cesa Scaglione; Caterina Tonon; Pietro Cortelli; Emil Malucelli; Sabina Capellari; Claudia Testa; Piero Parchi; Pasquale Montagna; Bruno Barbiroli; Raffaele Lodi
Journal:  Brain       Date:  2008-09-26       Impact factor: 13.501

9.  Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from Parkinson's disease.

Authors:  Giuseppe Nicoletti; Caterina Tonon; Raffaele Lodi; Francesca Condino; David Manners; Emil Malucelli; Maurizio Morelli; Fabiana Novellino; Sandra Paglionico; Pierluigi Lanza; Demetrio Messina; Paolo Barone; Letterio Morgante; Mario Zappia; Bruno Barbiroli; Aldo Quattrone
Journal:  Mov Disord       Date:  2008-12-15       Impact factor: 10.338

Review 10.  Update on progressive supranuclear palsy.

Authors:  Irene Litvan
Journal:  Curr Neurol Neurosci Rep       Date:  2004-07       Impact factor: 5.081

View more
  27 in total

1.  Track density imaging in progressive supranuclear palsy: A pilot study.

Authors:  Salvatore Nigro; Maria Giovanna Bianco; Gennarina Arabia; Maurizio Morelli; Rita Nisticò; Fabiana Novellino; Maria Salsone; Antonio Augimeri; Aldo Quattrone
Journal:  Hum Brain Mapp       Date:  2018-11-26       Impact factor: 5.038

2.  MRI gray and white matter measures in progressive supranuclear palsy and corticobasal syndrome.

Authors:  Neeraj Upadhyay; Antonio Suppa; Maria Cristina Piattella; Matteo Bologna; Flavio Di Stasio; Alessandra Formica; Francesca Tona; Carlo Colosimo; Alfredo Berardelli; Patrizia Pantano
Journal:  J Neurol       Date:  2016-07-13       Impact factor: 4.849

Review 3.  Neuroimaging in Dementia.

Authors:  Adam M Staffaroni; Fanny M Elahi; Dana McDermott; Kacey Marton; Elissaios Karageorgiou; Simone Sacco; Matteo Paoletti; Eduardo Caverzasi; Christopher P Hess; Howard J Rosen; Michael D Geschwind
Journal:  Semin Neurol       Date:  2017-12-05       Impact factor: 3.420

4.  Quality of life in patients with progressive supranuclear palsy: one-year follow-up.

Authors:  Tatjana Pekmezović; Milica Ječmenica-Lukić; Igor Petrović; Vladana Špica; Aleksandra Tomić; Vladimir S Kostić
Journal:  J Neurol       Date:  2015-06-13       Impact factor: 4.849

5.  [18 F]AV-1451 tau positron emission tomography in progressive supranuclear palsy.

Authors:  Jennifer L Whitwell; Val J Lowe; Nirubol Tosakulwong; Stephen D Weigand; Matthew L Senjem; Christopher G Schwarz; Anthony J Spychalla; Ronald C Petersen; Clifford R Jack; Keith A Josephs
Journal:  Mov Disord       Date:  2016-10-27       Impact factor: 10.338

6.  Neuroimaging evidence of gray and white matter damage and clinical correlates in progressive supranuclear palsy.

Authors:  Maria Cristina Piattella; N Upadhyay; M Bologna; E Sbardella; F Tona; A Formica; N Petsas; A Berardelli; P Pantano
Journal:  J Neurol       Date:  2015-05-16       Impact factor: 4.849

7.  Eye movements and association with regional brain atrophy in clinical subtypes of progressive supranuclear palsy.

Authors:  Ji-Hyun Choi; Heejung Kim; Jung Hwan Shin; Jee-Young Lee; Han-Joon Kim; Jong-Min Kim; Beomseok Jeon
Journal:  J Neurol       Date:  2020-09-21       Impact factor: 4.849

8.  Free-water imaging in Parkinson's disease and atypical parkinsonism.

Authors:  Peggy J Planetta; Edward Ofori; Ofer Pasternak; Roxana G Burciu; Priyank Shukla; Jesse C DeSimone; Michael S Okun; Nikolaus R McFarland; David E Vaillancourt
Journal:  Brain       Date:  2015-12-24       Impact factor: 13.501

9.  Topographic distribution of white matter changes and lacunar infarcts in neurodegenerative and vascular dementia syndromes: A post-mortem 7.0-tesla magnetic resonance imaging study.

Authors:  Jacques De Reuck; Florent Auger; Nicolas Durieux; Charlotte Cordonnier; Vincent Deramecourt; Florence Pasquier; Claude-Alain Maurage; Didier Leys; Regis Bordet
Journal:  Eur Stroke J       Date:  2016-05-18

Review 10.  Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?

Authors:  Jennifer L Whitwell; Günter U Höglinger; Angelo Antonini; Yvette Bordelon; Adam L Boxer; Carlo Colosimo; Thilo van Eimeren; Lawrence I Golbe; Jan Kassubek; Carolin Kurz; Irene Litvan; Alexander Pantelyat; Gil Rabinovici; Gesine Respondek; Axel Rominger; James B Rowe; Maria Stamelou; Keith A Josephs
Journal:  Mov Disord       Date:  2017-05-13       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.